CXCL9 and rheumatoid arthritis: Exosomes derived from miR-NC (control) or miR-320a transfected BM-MSCs suppressed CXCL9 expression, inhibited the activation and migration of FLSs, repressed inflammatory cytokines in vitro, and alleviated RA symptoms.